Volume 83, Issue 3, Pages (March 2013)

Slides:

Advertisements

Similar presentations

Stephen P. McDonald, Graeme R. Russ Kidney International

Advertisements

Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants C.A. Solid,

Mitchell H. Rosner, W. Kline Bolton Kidney International

End-stage renal disease in developing countries

Volume 83, Issue 3, Pages (March 2013)

Long-term follow-up of patients randomized to biocompatible or conventional peritoneal dialysis solutions show no difference in peritonitis or technique.

Kidney transplantation in a low-resource setting: Nigeria experience

Volume 80, Issue 10, Pages (November 2011)

Volume 79, Issue 6, Pages (March 2011)

Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Sanjeev Kumar, Stanley L.-S. Fan, Martin.

Volume 73, Issue 4, Pages (February 2008)

Volume 63, Issue 3, Pages (March 2003)

Steroid-free maintenance immunosuppression in kidney transplantation: is it time to consider it as a standard therapy? Fu L. Luan, Diane E. Steffick,

Steven J. Chadban, Natalie D. Staplin Kidney International

Volume 86, Issue 6, Pages (December 2014)

End-stage renal disease in living kidney donors

Steven G. Coca, Swathi Singanamala, Chirag R. Parikh

Volume 85, Issue 1, Pages (January 2014)

Comorbidity and confounding in end-stage renal disease

Volume 70, Issue 11, Pages (December 2006)

Volume 73, Issue 7, Pages (April 2008)

Volume 77, Issue 2, Pages (January 2010)

Volume 78, Issue 10, Pages (November 2010)

Stephen P. McDonald Kidney International Supplements

Volume 87, Issue 4, Pages (April 2015)

Volume 85, Issue 6, Pages (June 2014)

Volume 92, Issue 3, Pages (September 2017)

U-shaped effect of eGFR and mortality

Volume 76, Issue 10, Pages (November 2009)

Volume 70, Issue 12, Pages (December 2006)

Volume 76, Issue 6, Pages (September 2009)

Volume 76, Issue 6, Pages (September 2009)

Volume 83, Issue 5, Pages (May 2013)

Elevated risk of stroke among patients with end-stage renal disease

Racial disparities in access to transplantation: a tough nut to crack

Volume 76, Issue 8, Pages (October 2009)

Atrial fibrillation in end-stage renal disease: an emerging problem

Counteracting progression of renal disease: A look into the future

A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease S. Susan Hedayati, Venkata Yalamanchili,

Michael J. Germain, MD, Sara N. Davison, MD, Alvin H. Moss, MD

Volume 84, Issue 4, Pages (October 2013)

Volume 71, Issue 12, Pages (June 2007)

Volume 87, Issue 5, Pages (May 2015)

Volume 54, Issue 2, Pages (August 1998)

Stephen P. McDonald, Graeme R. Russ Kidney International

Volume 77, Issue 12, Pages (June 2010)

Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients B. Bammens, P. Evenepoel, H. Keuleers,

Long-term survival in renal transplant recipients with graft function

Racial differences in survival of patients on dialysis

Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants C.A. Solid,

Peritoneal dialysis in Mexico

Low triiodothyronine and survival in end-stage renal disease

Volume 76, Issue 6, Pages (September 2009)

Does equal care give equal outcomes?

The Iranian model of living renal transplantation

Stephen P. Mcdonald, Graeme R. Russ Kidney International

Volume 80, Issue 10, Pages (November 2011)

Volume 64, Issue 5, Pages (November 2003)

Volume 71, Issue 12, Pages (June 2007)

Charles A. Herzog Kidney International

Volume 87, Issue 3, Pages (March 2015)

Membranous nephropathy: recent travels and new roads ahead

Volume 70, Issue 10, Pages (November 2006)

Volume 88, Issue 5, Pages (November 2015)

Abby S. Kazley, Kit N. Simpson, Kenneth D. Chavin, Prabhakar Baliga

Familial phenotype differences in PKD11

Prediction in idiopathic membranous nephropathy

A Randomized Controlled Trial of Coiled Versus Straight Swan-Neck Tenckhoff Catheters in Peritoneal Dialysis Patients David W. Johnson, PhD, Jennifer.

Stephen Pastan, J. Michael Soucie, William M. McClellan

Ronen Levi, Justin Silver Kidney International

Presentation transcript:

Volume 83, Issue 3, Pages 503-510 (March 2013) Anti-glomerular basement membrane antibody disease is an uncommon cause of end- stage renal disease Wen Tang, Stephen P. McDonald, Carmel M. Hawley, Sunil V. Badve, Neil C. Boudville, Fiona G. Brown, Philip A. Clayton, Scott B. Campbell, Janak R. de Zoysa, David W. Johnson Kidney International Volume 83, Issue 3, Pages 503-510 (March 2013) DOI: 10.1038/ki.2012.375 Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 1 Kaplan–Meier survival curves for anti-glomerular basement membrane (anti-GBM) disease end-stage renal disease (ESRD) and other causes of ESRD in Australian and New Zealand dialysis patients between 1963 and 2010. The difference between the groups was statistically significant (log-rank score 13.5, P<0.001). Outcomes were censored for renal function recovery, loss to follow-up, renal transplantation, and end of study. Kidney International 2013 83, 503-510DOI: (10.1038/ki.2012.375) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 2 Kaplan–Meier death-censored first graft survival curves for anti-glomerular basement membrane (anti-GBM) disease end-stage renal disease (ESRD) and other causes of ESRD undergoing renal transplantation in Australia and New Zealand between 1963 and 2010. The difference between the groups was not statistically significant (log-rank score 1.23, P=0.27). Kidney International 2013 83, 503-510DOI: (10.1038/ki.2012.375) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 3 Kaplan–Meier death-censored first graft survival curves for patients with anti-glomerular basement membrane (anti-GBM) disease end-stage renal disease (ESRD) who received a transplant <1 year or ≥1 year after starting dialysis. The difference between the groups was not statistically significant (log-rank score 0.73, P=0.39). Kidney International 2013 83, 503-510DOI: (10.1038/ki.2012.375) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 4 Kaplan–Meier patient survival curves for anti-glomerular basement membrane (anti-GBM) disease end-stage renal disease (ESRD) and other causes of ESRD undergoing first renal transplantation in Australia and New Zealand between 1963 and 2010. The difference between the groups was not statistically significant (log-rank score 3.09, P=0.08). Kidney International 2013 83, 503-510DOI: (10.1038/ki.2012.375) Copyright © 2013 International Society of Nephrology Terms and Conditions